Arch Venture Management, LLC Natera, Inc. Transaction History

Arch Venture Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $2.36 Million - $3.76 Million	64,441 New	64,441 $3.58 Million
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $973,211 - $2.93 Million	-32,098 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $2.77 Million - $3.82 Million	32,098 New	32,098 $3 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Arch Venture Management, LLC with notifications on news.